Rebekah...As you say, when and if we receive regulatory approvals for ATH434 for MSA from the FDA and other worldwide agencies, I think there will be speedy and significant off-label usage by Parkinson's patients at the recommendation of their neurologists. That would be nice, lucrative, and hopefully bode well for our future clinical trials for Parkinson's too.
Rebekah...As you say, when and if we receive regulatory...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $203.0K | 45.14M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 103 | 103186567 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 31969254 | 19 |
View Market Depth
| Last trade - 10.53am 30/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |